A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The present protocol describes new tools for SPR binding assays to examine CV-N binding to HA, S glycoprotein, related hybrid-type glycans, and high-mannose oligosaccharides. SPR is used to determine the KD for binding either dimeric or monomeric CV-N to these glycans.

Abstract

Surface plasmon resonance (SPR) is used to measure hemagglutinin (HA) binding to domain-swapped Cyanovirin-N (CV-N) dimer and to monitor interactions between mannosylated peptides and CV-N's high-affinity binding site. Virus envelope spikes gp120, HA, and Ebola glycoprotein (GP) 1,2 have been reported to bind both high- and low-affinity binding sites on dimeric CVN2. Dimannosylated HA peptide is also bound at the two low-affinity binding sites to an engineered molecule of CVN2, which is bearing a high-affinity site for the respective ligand and mutated to replace a stabilizing disulfide bond in the carbohydrate-binding pocket, thus confirming multivalent binding. HA binding is shown to one high-affinity binding site of pseudo-antibody CVN2 at a dissociation constant (KD) of 275 nM that further neutralizes human immunodeficiency virus type 1 (HIV-1) through oligomerization. Correlating the number of disulfide bridges in domain-swapped CVN2, which are decreased from 4 to 2 by substituting cystines into polar residue pairs of glutamic acid and arginine, results in reduced binding affinity to HA. Among the strongest interactions, Ebola GP1,2 is bound by CVN2 with two high-affinity binding sites in the lower nanomolar range using the envelope glycan without a transmembrane domain. In the present study, binding of the multispecific monomeric CV-N to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein is measured at KD = 18.6 µM as compared with nanomolar KD to those other virus spikes, and via its receptor-binding domain in the mid-µ-molar range.

Introduction

Tetherin-associated antiviral activity is induced by interferon-α, and it comprises protein-based tethers, that leads to the retention of fully formed virions on infected cell surfaces1. The necessity for tetherin glycosylation in the inhibition of virus release remains uncertain, implying the importance of glycosylation patterns on recombinantly expressed glycans for in vitro studies1,2, which depends on the conformation of (in the case of influenza virus) surface-expressed influenza hemagglutinin HA3,4. It has be....

Protocol

For the present study, a CVN-small ubiquitin-like modifier (SUMO) fusion protein has been used in enzyme-linked immunosorbent assays instead of CV-N and is suitable for cell-based assays. Recombinant full-length influenza A virus HA H3 protein is obtained commercially (see Table of Materials) or expressed in mammalian HEK293 cell lines and baculovirus-infected insect cells according to standard protocols12. Wuhan-1 spike protein is expressed in mammalian HEK293 cells. The synthesis of monomannosylated peptide (MM) and dimannosylated peptide (DM) allows the detection of homogeneous ligands to CVN2 and monomannosylated small mole....

Representative Results

A dimeric domain-swapped CVN2L0 molecule is tested for binding to the HA top region in three separate SPR experiments and binding affinity is presented in KD values. Domain B is assumed to comprise H-binding sites, which are impacted by replacing a disulfide bond into ionic residues, and domain A forms L10,18. Single injections of CVN2L0 and variants V2 (three disulfide bridges) and V5 (two disulfide bridges) are first tested for binding to the HA-coup.......

Discussion

CV-N's binding affinity is correlated with the number of functional binding sites [2H on domains B, and 2L on domain(s) A when engineered as domain-swapped dimer]. A variant with an altered binding affinity (CVN2L0-V2, a homodimeric stable fold of CV-N comprising a disulfide bridge knock-out) is expressed in E. coli, purified, and positively tested for binding to HA-protein (H3N2) using SPR10, and shows a conformational change upon binding HA with either H or L carbohydrate-binding si.......

Disclosures

The author has nothing to disclose.

Acknowledgements

The author acknowledges Dr. Christian Derntl from the Department for Biotechnology and Microbiology at the TU Wien and the Department of Medicine III, Division of Nephrology and Dialysis at the Medical University of Vienna, especially Dr. Markus Wahrmann for technical and scientific support. Protein expression in mammalian cells was supported by the Department of Biotechnology at the University of Natural Resources and Life Sciences (BOKU) Vienna. The author wants to express her deep acknowledgement to Dr. Nico Dankbar from XanTec bioanalytics in Duesseldorf, Germany, for helpful scientific discussions on performing the SPR binding assays.

....

Materials

NameCompanyCatalog NumberComments
Äkta primeplusCytiva
Amicon tubesMerckC7715
AmpillicinSigma-AldrichA5354
Beckmann Coulter Cooler Allegra X-30R centrifugeBeckman CoulterB06320
Cell spreaderSigma-AldrichHS86655silver stainless steel, bar L 33 mm
Custom DNA OligosSigma-AldrichOLIGO
Custom GensynthesisGenScript#1390661 cloning vector: pET27b(+) 
Cytiva HBS-EP+ Buffer 10, 4x50mLThermo Scientific50-105-5354
Dionex UlitMate 3000Thermo ScientificIQLAAAGABHFAPBMBFB
Dpn I restriction enzyme (10 U/μL) Fisher ScientificER1701
DTTMerckDTT-RO
EDCMerck39391
EDTAMerckE9884
Eppendorf Safe-Lock TubesEppendorf30120086
Eppendorf Safe-Lock TubesEppendorf30120094
Eppendorf Minispin and MiniSpin Plus personal microcentrifugeSigma-AldrichZ606235
EthanolMerck51976
Ethanolamine HClMerckE6133
Falcon 50mL Conical Centrifuge TubesFisher Scientific14-432-22
Falcon 14 mL Round Bottom Polystyrene Test Tube, with Snap Cap, Sterile, 25/PackCorning352057
GlucoseMerckG8270
Glycine HClMerck55097
HA H3 proteinAbcamab69751
HEPESMerckH3375
His-select Ni2+MerckH0537
ImidazoleMerckI2399
IPTGMerckI6758
Kanamycin ASigma-AldrichK1377
Kromasil 300-5-C4Nouryon
LB agarMerck52062
LB agarMerck19344
LB LennoxMerckL3022
LysozymeMerck10837059001
Magnesium chlorideMerckM8266
Magnesium sulfateMerckM7506
NaH2P04MerckS0751
NanoDrop UV-Vis2000c spectrophotometerThermo ScientificND2000CLAPTOP
NaOHMerckS5881
NHSMerck130672
NZ amine (casein hydrolysate)MerckC0626
PBSMerck806552
PD MidiTrap G-10Sigma-AldrichGE28-9180-11
PeptoneMerck70171
pET11aMerck Millipore (Novagen)69436 
PMSFMerckPMSF-RO
QIAprep Spin Miniprep Kit (1000)Qiagen27106X4
Reichert Software Package Autolink1-1-9Reichert
Reichert SPR SR7500DC Dual Channel SystemReichert
Scrubber2-2012-09-04 for data analysisReichert
SDSMerck11667289001
Site-directed mutagenesis kit incl pUC18 control plasmidStratagene#200518
Sodim chlorideMerckS9888
Sodium acetate.TrihydrateMerck236500
SPR sensor chip C19RBDHC30MXanTec bioanalyticsSCR C19RBDHC30M
SPR sensor chip CMD500DXanTec bioanalyticsSCR CMD500D
Sterilin Standard 90mm Petri DishesThermo Scientific101R20
TBSMerckT591210x, solution
Triton-X100MerckT8787
TryptoneMerck93657
Tween20MerckP1379
Vortex-Genie 2 MixerMerckZ258423
X-galMerckXGAL-RO
XL1-Blue Supercompetent CellsStratagene#200236
Yeast extractMerckY1625

References

  1. Perez-Caballero, D., et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell. 139 (3), 499-511 (2009).
  2. Waheed, A. A., Gitzen, A., Swiderski, M., Freed, E. O.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Surface Plasmon ResonanceSPRProtein ligand InteractionsVirus BindingKinetic AnalysisDrug DevelopmentAntibody CharacterizationDNA TemplateDpnI DigestionCompetent CellsTransformationSeed CultureExpression Culture

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved